3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
52
Carcinoma, Renal Cell
25
Liver Neoplasms
23
Neoplasms
19
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
16
Kidney Neoplasms
11
Leukemia, Myeloid, Acute
9
Melanoma
8
Glioblastoma
8
Sarcoma
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Brain Neoplasms
7
Thyroid Neoplasms
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Gliosarcoma
5
Urinary Bladder Neoplasms
4
Recurrence
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia
4
Carcinoma
4
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leiomyosarcoma
3
Interventions
Ribavirin
4
ledipasvir, sofosbuvir drug combination
2
Sofosbuvir
2
telaprevir
1
pembrolizumab
1
peginterferon alfa-2a
1
grazoprevir
1
elbasvir-grazoprevir drug combination
1
elbasvir
1
Rapid Diagnostic Tests
1
Immunoenzyme Techniques
1
Hypothermia, Induced
1
Enzyme-Linked Immunosorbent Assay
1
Chromatography, High Pressure Liquid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hepatitis C
×
Sorafenib
×
Clear all
No trials found.